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ABSTRACT
To understand the biology of cancer, joint analysis of
multiple data modalities, including imaging and genomics,
is crucial. We propose the use of canonical correlation anal-
ysis (CCA) and a sparse variant as a preliminary discovery
tool for identifying connections across modalities, specifi-
cally between gene expression and features describing cell
and nucleus shape, texture, and stain intensity in histopatho-
logical images. Applied to 615 breast cancer samples from
The Cancer Genome Atlas, CCA revealed significant corre-
lation of several image features with expression of PAM50
genes, known to be linked to outcome, while Sparse CCA re-
vealed associations with enrichment of pathways implicated
in cancer without leveraging prior biological understanding.
These findings affirm the utility of CCA for joint phenotype-
genotype analysis of cancer.
1. INTRODUCTION
Cancer is a complex disease arising from molecular alter-
ations that interact with and obstruct normal biological pro-
cesses and produce phenotypic changes. Imaging modali-
ties, such as microscopic imaging of hematoxylin-and-eosin
(H&E) stained slides and high-throughput genomics provide
complementary information about the phenotypic traits (such
as cell morphology) and molecular traits (such as gene ex-
pression and mutations) in a tumor. The Cancer Genome At-
las (TCGA) [1] provides rich resources of imaging, genomic,
and clinical data and exemplifies the growing interest in com-
prehensive phenotypic and genomic data sets for disease un-
derstanding.
To explore connections between multiple data modalities,
correlation analysis is the most straightforward approach.
However, since gene expression is the product of complex
interacting cellular processes, cross-modality connections
should be made that consider their relative levels and not just
pairwise relationships. A recent effort to explore correlation
analysis for paired image and genomic data is the work by
Cooper et al. [2]. The authors extracted human-annotated
measures of necrosis and angiogenesis, along with cellular
features, from histopathological images of glioblastomas and
studied their correlation with gene expression. To incorporate
interactions between genes, each patient’s gene expression
Fig. 1. CCA workflow for imaging-genomics
was represented as a mixture of clustered gene signatures
derived from the data.
Canonical correlation analysis (CCA) [3] is an alterna-
tive approach for exploration that extends pairwise corre-
lation analysis by considering linear combinations of the
variables of each modality. An advantage of CCA is that
it requires no preprocessing of gene expression or image
features to incorporate their interactions, but rather learns
them via the linear model. A sparsity-based extension is
Sparse CCA (SCCA) [4], which makes CCA possible for
high-dimensional data with few samples and is particularly
suited for gene expression.
We explored the use of CCA and SCCA for unbiased dis-
covery of connections between histopathological image fea-
tures and gene expression of breast cancer tumors. In partic-
ular, we extracted cellular features of shape, color, and tex-
ture from images using CellProfiler [5] and a reliable, effi-
cient patch-based approach for nuclear segmentation using
convolutional neural networks (CNNs) [6]. Using CCA, we
discovered a significant correlation of 0.763 (p ≈ 1e−14)
between the texture and shape features of cells and the ex-
pression of PAM50 genes, and enabled a separation of pa-
tients based on subtypes without leveraging specific subtype
information. Using SCCA, we discovered a correlation of
0.471 (p ≈ 7e−3) between a subset of image features and
genes. Pathway analysis of the selected subset of genes using
DAVID [7] revealed a meaningful connection between cell
size and several genes related to immune response. Based
upon these findings, we propose the use of CCA and its sparse
variant as a preliminary discovery tool for imaging-genomic
connections.
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2. IMAGING-GENOMICS AND CCA
Our overall CCA workflow on paired histopathological im-
ages and gene expression of patients is shown in Fig 1, which
consists of nuclear and cellular segmentation and feature ex-
traction, and CCA and SCCA to discover significant connec-
tions between images and gene expression.
2.1. Nuclear Segmentation and Feature Extraction
In diagnosing breast cancer, the morphology and granularity
of nuclei is an important indicator. Therefore, we employed
computational image analysis methods to extract quantitative
features describing these qualities of cells and their nuclei.
We have developed a reliable and efficient patch-based CNN
approach for segmentation [6], similar to that recently pro-
posed by Janowczyk and Madabhushi [8], which scans an
image patch-by-patch and produces a binary label for each
patch, indicating if the center pixel of the patch is contained
within a nucleus or not.
Our patch-based CNN produces a full binary nuclear seg-
mentation mask, which is then fed to CellProfiler [5], along
with the corresponding H&E image, to refine the segmen-
tation and extract quantitative features describing the shape,
texture, and color of the nuclei and cells. To summarize these
features across all of the cells of the image, the mean, standard
deviation, and percentiles at increments of 10% of the distri-
bution of each feature are calculated. This yielded ∼ 2400
unique statistics of image features, which defined the image
feature vector for the corresponding patient. Since analyzing
entire WSIs is computationally demanding, we manually se-
lected several representative patches from the tumor regions
of each WSI and calculated the image feature vectors based
on these patches, for each patient.
2.2. Canonical Correlation Analysis
For the imaging-genomics formulation, letX ∈ Rn×p denote
the matrix of expression levels of p genes for n patients and
Y ∈ Rn×q denote the matrix of q image features for the same
n patients. To understand the information shared between X
andY, we make use of CCA and its sparse variant.
Introduced by Hotelling [3], CCA is a method for deter-
mining the linear relationship between two sets of variables.
Given two sets of variables, X and Y, attributed to the same
n samples, CCA seeks linear combinations of the variables in
each domain that are maximally correlated with each other.
Formally, CCA seeks α ∈ Rp and β ∈ Rq that maximize the
objective function
max
α,β
αTXTYβ such that αTXTXα = βTYTYβ = 1,
where the columns ofX andY are standardized to mean zero
and unit variance. The vectors α and β are referred to as the
canonical weights and Xα and Yβ are the canonical vari-
ates. This process can be repeated to find k dimensions of
canonical variates. Similar to principal component analysis,
orthogonality constraints are imposed such that correspond-
ing variates are orthogonal to previously found pairs. The
correlations of each variable of each domain with its corre-
sponding canonical variate are called the canonical loadings.
For example, for image feature f1 and the first variate Yβ1,
both ∈ Rp, the loading L(f1,Yβ1) = corr(f1,Yβ1) where
corr(·) is the Pearson’s correlation. Here, we employ CCA
to obtain the canonical weights, and hence the canonical vari-
ates, and look to identify the genes and image features of most
importance in the variate space.
For most of the genomic data used today, n  max(p, q),
while CCA is only suitable when n ≥ max(p, q). Applying
CCA to high-dimensional, low-sample data therefore requires
selecting a subset of the features in advance, or first mapping
the features to a lower dimensional space, limiting the util-
ity of the approach. To overcome this issue, many versions
of penalized CCA have been proposed, which can work for
high-dimensional data, while preserving interpretability.
We work with the formulation described by Witten et
al. [4]. Called SCCA, this method optimizes the objective
function
max
α,β
αTXTYβ,
such that ‖α‖2 ≤ 1, ‖β‖2 ≤ 1, Px(α) ≤ cx, Py(β) ≤ cy,
where Px and Py are convex penalty functions, often chosen
to impose sparsity. For our analysis, we chose the L1 penalty
function. For multiple variates, the algorithm is iterated.
3. RESULTS AND DISCUSSION
We applied the overall method on 615 breast invasive car-
cinoma (BRCA) patients from TCGA. Histopathological
images for TCGA patients are in the form of whole slides
(WSIs), and in order to reduce the computational burden of
image analysis and to avoid contamination in the analysis
by normal cells near the tumor, we manually selected up
to fifteen representative patches of 1000×1000 pixels from
each WSI in the tumor region for segmentation and feature
extraction. Gene expression was retrieved from TCGA using
cBioPortal, which normalized expression levels to z-scores.
The analyses are done in R using the default CCA package
and the SCCA package provided by Witten et al. [4].
3.1. Using CCA
To apply CCA to the extracted image features and gene ex-
pression of TCGA-BRCA patients, we first had to select a
smaller subset of both image features and genes such that
max(p, q) < n. Of the image features, we used only the
mean and standard deviation of the shape, texture and color
features, which resulted in 84 image features per patient. As a
(a) (b)
(c)
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Fig. 2. Canonical loadings of image features (a)(d) and expression of genes (b)(e) based on CCA(top row) and SCCA(bottom
row), horizontal axis: genes/image-features, vertical axis: variate number, (c) shows the mapping of patients onto the 1st variate
meaningful subset of genes to analyze, we chose the PAM50
set of 50 genes, which has been shown to be discriminative of
the general grouping of patients into molecular subtypes [9].
Using CCA on these restricted sets of variables, we found
four canonical variates of statistical significance (p-value
less than 0.05, computed using Wilk’s lambda statistic) with
strong correlation ({0.76, 0.64, 0.61, 0.59} respectively). Be-
yond the first four variates, the significance of the correlation
quickly dropped. To interpret the learned canonical variates,
we examined the canonical loadings of each image feature
and gene with each variate, which are shown in Fig. 2(a)(b).
We observe that the first canonical variate is highly cor-
related with many PAM50 genes, with correlations as high
as 0.8, which implies that this variate is highly representative
of PAM50 expression. The loadings of the image features in
Fig. 2(a) are grouped by category, which reveals the strongest
correlation for most variates is with several texture features of
the hematoxylin stain, area, and shape. The first variate shows
a strong positive correlation particularly with texture features
describing the entropy and variance of the hematoxylin stain
within the nucleus and shape features describing the nucleus.
Subsequent variates showed much lower loadings, so while
still significantly correlated within their imaging counterpart,
the interpretation is not as clear.
To further understand the first variate, the 615 patients are
mapped into the corresponding variate space. The scatter plot
of the mappings (αTX, βTY on x and y axes, respectively)
is shown in Fig. 2(c), with the color representing the true sub-
type. Luminal A patients are clustered towards the left, and
Basal patients to the right, while HER2 and Luminal B pa-
tients are spread out in between. This spread of the subtypes
is, interestingly, in accordance with the expected prognosis of
the patients. It is also noted that the range of values in the
image variate is considerably smaller than those of the genes,
suggesting that we should consider a more diverse set of im-
age features.
Though CCA can potentially pick any relevant linear
combination of features resulting in any possible ordering of
the subtypes, the result of information from both modalities
was a meaningful order of subtypes: Luminal A, Luminal B,
HER2 and Basal. Thus, while it is known that the PAM50
gene set is indicative of molecular subtype, CCA was able
to identify the particular combination of genes and image
features which can map patients into the subtype, without
leveraging particular subtype information.
3.2. Using SCCA
In contrast to CCA, we were able to analyze all image fea-
tures and genes using SCCA, allowing the algorithm to dis-
cover which subset of each is most correlated. Using an L1
penalty factor of 0.1 for both image and genomic variables,
we obtained sets of 45-60 genes and 30-45 image features
with non-zero weights for each of the ten canonical variates,
respectively, with correlations in the range of 0.35-0.47, with
an overall p-value of 0.001. To interpret the learned canonical
variates of SCCA, we make use of the loadings as before, as
shown in Fig. 2(d)(e). The category of ‘cell’ indicates that the
feature is of the cytoplasmic region surrounding the nucleus,
which mostly describe area and shape. All other features are
extracted from the nucleus only.
Since SCCA can consider all genes and image features, it
can reveal novel, unbiased phenotype-genotype associations.
We selected genes whose expression levels were highly cor-
related (> 0.35) with the canonical variates discovered by
SCCA and investigated their collective function using the on-
line functional annotation tool DAVID [7], which can test for
association of gene sets with KEGG pathways. The KEGG
pathways significantly associated are shown in Fig 3.
The first variate and others showed a similar correlation
pattern with both image features and gene expressions, which
is likely a result of the lack of enforcement of orthogonal-
Fig. 3. Plot of variates vs pathways defined by genes with correlation > 0.35 based on SCCA (Intensity of color represents the
-log(p-value), the number is the percentage of pathway genes overlapping with 0 meaning not computed).
ity by SCCA. DAVID revealed that, for the first variate, the
highly correlated genes were strongly associated with path-
ways related to immune response, including primary immun-
odeficiency, natural killer cell mediated cytotoxicity, and to
lymphocytes, including Th1 and Th2 cell differentiation, T-
cell and B-cell receptor signaling, and NF-kappa B signaling.
Fig. 2(d)(e) shows that the expression of these genes has a
strong correlation with area and shape features through the
latent canonical variates. Given that lymphocytes are eas-
ily distinguished by their small size and circular shape, we
could hypothesize that these canonical variates are capturing
image and genomic descriptions of the presence of lympho-
cytes within the tumor, which is indeed a biologically relevant
association for cancer.
Variates five, six, and ten capture texture and cell hema-
toxylin features, which are indicative of DNA content, and
intensity features of both stains. These variates were found to
be correlated with gene sets associated with the cell cycle and
p53 signaling pathways (related to DNA damage repair and
apoptosis), all of which have important implications for tumor
development. The second variate too could have implications
for cancer, as it was associated with pathways involved in cell
processes such as cell maintenance (ECM-receptor interac-
tion), adhesion (focal adhesion), and proliferation (Wnt sig-
naling and proteoglycans in cancer), and the cycle (PI3K-Akt
signaling), though the lack of strong correlation with particu-
lar image features necessitates further investigation for a clear
interpretation.
4. CONCLUSIONS AND FUTUREWORK
We have demonstrated the utility of CCA and SCCA in dis-
covering connections between cellular features and gene ex-
pressions for breast cancer. The learned canonical variates
represent latent spaces that link the two modalities and pro-
vide insight into their joint variation. Their biological rele-
vance was shown through their association with diverse path-
ways with implications for cancer, and could benefit from a
more diverse range of image features. We envision that such
a correlation analysis could be a preliminary step in studies
of phenotypic and genomic traits, with follow-up affirmation
and testing by pathologists and biologists, toward new in-
sights into genetic diseases.
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